Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease

Journal of Crohn's and Colitis

Volumn 7, Issue 12, 2013, Pages 950-957

  Van Assche, Gert ^a,b   Herrmann, Karin A ^c   Louis, Edouard ^d   Everett, Simon M ^f   Colombel, Jean Frédéric ^e   Rahier, Jean François ^g   Vanbeckevoort, Dirk ^a   Meunier, Paul ^d   Tolan, Damian ^f   Ernst, Olivier ^e   Rutgeerts, Paul ^a   Vermeire, Séverine ^a   Aerden, Isolde ^a   Oortwijn, Alessandra ^h   Ochsenkühn, Thomas ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF TORONTO   (Canada)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^g Centre Hospitalier Universitaire UCL Mont Godinne   (Belgium)

^h Centocor BV   (Netherlands)

Author keywords

Anti TNF therapy; Complications; Crohn's disease; Imaging; MR enteroclysis

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CONTRAST MEDIUM; GADOLINIUM PENTETATE MEGLUMINE; INFLIXIMAB; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONSCIOUSNESS DISORDER; CONTRAST ENHANCEMENT; CROHN DISEASE ACTIVITY INDEX; DISEASE SEVERITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL TRACT EXAMINATION; HUMAN; ILEAL CROHN DISEASE; ILEUM DISEASE; INTENTION TO TREAT ANALYSIS; LOSS OF RESPONSE; MAGNETIC RESONANCE ENTEROCLYSIS; MAINTENANCE THERAPY; MALE; MRE SCORE OF SEVERITY IN ILEAL CROHN SISEASE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; PANCREATITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SKIN DEFECT; TREATMENT RESPONSE;

ANTI-TNF THERAPY; COMPLICATIONS; CROHN'S DISEASE; IMAGING; MR ENTEROCLYSIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; C-REACTIVE PROTEIN; CONTRAST MEDIA; CROHN DISEASE; FEMALE; GADOLINIUM; HUMANS; ILEITIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84887610662     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.01.011     Document Type: Article

References (25)

1. Rutgeerts P., Feagan B.G., Lichtenstein G.R., Mayer L.F., Schreiber S., Colombel J.F., et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 2004, 126:402-413.
2. Louis E., Boverie J., Dewit O., Baert F., De Vos M., D'Haens G., et al. Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study. Acta Gastroenterol Belg 2007, 70:15-19.
3. Lichtenstein G.R., Olson A., Travers S., Diamond R.H., Chen D.M., Pritchard M.L., et al. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease. Am J Gastroenterol 2006, 101:1030-1038.
4. Van Assche G., Dignass A., Panes J., Beaugerie L., Karagiannis J., Allez M., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010, 4:7-27.
5. Sempere G.A.J., Martinez Sanjuan V., Medina Chulia E., Benages A., Tome Toyosato A., Canelles P., et al. MRI evaluation of inflammatory activity in Crohn's disease. AJR 2005, 184:1829-1835.
6. Bodily K.D., Bodily K.D., Fletcher J.G., Solem C.A., Johnson C.D., Fidler J.L., et al. Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography-correlation with endoscopic and histologic findings of inflammation. Radiology 2006, 238:505-516.
7. Frokjaer J.B., Larsen E., Steffensen E., Nielsen A.H., Drewes A.M. Magnetic resonance imaging of the small bowel in Crohn's disease. Scand J Gastroenterol Jul 2005, 40(7):832-842.
8. Masselli G., Casciani E., Polettini E., Gualdi G. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn's disease. Eur Radiol 2008, 18:438-447.
9. Ochsenkuhn T., Herrmann K., Schoenberg S.O., Reiser M.F., Goke B., Sackmann M. Crohn disease of the small bowel proximal to the terminal ileum: detection by MR-enteroclysis. Scand J Gastroenterol Oct 2004, 39(10):953-960.
10. Rimola J., Rodriguez S., García-Bosch O., Ordás I., Ayala E., Aceituno M., et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 2009, 58:1113-1120.
11. Rimola J., Ordás I., Rodriguez S., García-Bosch O., Aceituno M., Llach J., et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011, 17:1759-1768.
12. Zappa M., Stefanescu C., Cazals-Hatem D., Bretagnol F., Deschamps L., Attar A., et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis 2011, 17:984-993.
13. Bruining D.H., Loftus E.V., Ehman E.C., Siddiki H.A., Nguyen D.L., Fidler J.L., et al. Computed tomography enterography detects intestinal wall changes and effects of treatment in patients with Crohn's disease. Clin Gastroenterol Hepatol 2011, 9:679-683.
14. Punwani S., Rodriguez-Justo M., Bainbridge A., Greenhalgh R., De Vita E., Bloom S., et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 2009, 252:712-720.
15. Taylor S.A., Punwani S., Rodriguez-Justo M., Bainbridge A., Greenhalgh R., De Vita E., et al. Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination-pilot study. Radiology 2009, 251:369-379.
16. Grieser C., Denecke T., Steffen I. Magnetic resonance enteroclysis in patients with Crohn's disease: fat saturated T2-weighted sequences for evaluation of inflammatory activity. J Crohns Colitis 2012, 6:294-301. Original Research Article.
17. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology Mar 1976, 70(3):439-444.
18. Harvey R.F., Bradshaw J.M. A simple index of Crohn's-disease activity. Lancet 1980, 1:514.
19. Guyatt G., Mitchell A., Irvine E.J., Singer J., Williams N., Goodacre R., et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989, 96:804-810.
20. Cosnes J., Nion-Larmurier I., Beaugerie L., Afchain P., Tiret E., Gendre J.-P. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005, 54:237-241.
21. Johnson L.A., Luke A., Sauder K., Moons D.S., Horowitz J.C., Higgins P.D. Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a "Top-Down" approach to intestinal fibrosis in mice. Inflamm Bowel Dis 2012, 18:460-471.
22. Targan S.R., Hanauer S.B., van Deventer S.J., Mayer L., Present D.H., Braakman T., et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997, 337:1029-1035.
23. Colombel J.F., Solem C.A., Sandborn W.J., Booya F., Loftus E.V., Harmsen W.S., et al. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C-reactive protein. Gut 2006, 55:1561-1567.
24. Colombel J.F., Sandborn W.J., Reinisch W., Mantzaris G.J., Kornbluth A., Rachmilewitz D., et al. SONIC Study Group. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med Apr 15 2010, 362:1383-1395.
25. Jürgens M., Mahachie John J.M., Cleynen I., Schnitzler F., Fidder H., van Moerkercke W., et al. Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease. Clin Gastroenterol Hepatol 2011, 9:421-427.